Journal Club - Recent Additions

June - 2020

Previous Next    

Showing Journal 2 of 7


Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

J Goldman, D Lye, D Hui, etal for the GS-US-540-5773 Investigators New Eng J Med, 2020, online May

Comment

The RNA polymerase inhibitor remdesivir has shown nanomolar in-vitro activity against SARS-CoV-2 in human airway epithelial cells and clinical and virologic efficacy in a primate model of SARS-CoV-2. It has safety data in humans infected with Ebola virus. 

This randomised,...


June



Previous Comments

No Comments yet.